Bioelectronics Corp (BIEL)

[GetSeriousOK]

Staelin's description of the MundiPharma "contract" sure sounds different from the PR's in 2018:

https://www.bielcorp.com/bioelectronics-actipatch-musculoskeletal-therapy-added-to-mundipharma-australias-pain-portfolio/

https://www.globenewswire.com/en/news-release/2018/11/15/1652277/0/en/BioElectronics-Signs-a-Five-Country-Additional-Distribution-Agreement-with-Mundipharma-Pty-Limited-South-East-Asia.html

In 2018 it was just a Distribution Agreement. First, in July, they "[acquired] the exclusive Australian and New Zealand distribution rights to the ActiPatch® Musculoskeletal Pain Therapy medical device." Then, in November, they "[acquired] the distribution rights in South East Asia, for Singapore, Malaysia, Thailand, Indonesia and the Philippines." Now Staelin is saying it was a contractual promise to buy $14 million worth of product?

Yeah right.